Genedrive's CYP2C19 ID Kit included in UK's NICE assessment
(Alliance News) - Genedrive PLC on Monday said the UK's National Institute for Health & Clinical Excellence has begun an evaluation of CYP2C19 genotype testing for Clopidogrel treatment. Read More